CFAP20DC
GeneCFAP20 domain containing
Gene summary
No gene description available in the current model. Review primary literature for detailed gene function and characteristics.
- C3orf67
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~332.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0016575
Submitter: LiferaOmics
CFAP20DC was first reported in association with autosomal-recessive primary ciliary dyskinesia in 2025 in a Saudi pediatric patient homozygous for the nonsense variant NM_198463.2:c.508C>T, p.(Arg170Ter), corresponding to NM_001394063.1:c.883C>T, p.(Arg295Ter). A subsequent multicenter study by Gerard et al., 2026 identified 24 affected individuals from 16 families and seven countries with eight distinct biallelic CFAP20DC variants, including nonsense, frameshift, canonical splice-site, multiexon deletion, in-frame deletion alleles, and recurrent p.(Arg295Ter) cases. Affected individuals suffered from chronic and severe airway disease marked by early-age onset of bronchiectasis, predominantly in the middle and lower lungs, and absence of ciliary ultrastructural defects. Case-level evidence reaches the ClinGen maximum of 12 genetic evidence points. Experimental evidence includes enrichment of CFAP20DC expression in deuterosomal cells and functional abnormalities in patient-derived respiratory epithelial cells. Affected cells showed cytoplasmic mislocalization and abnormal orientation of basal bodies, reduced generation of multiple motile cilia, abnormal localization of the basal-foot marker CNTRL, and markedly impaired ciliary particle transport. No convincing contradictory evidence was identified. The combined evidence score is 14.5 points, comprising 12 genetic and 2.5 experimental evidence points.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CFAP20DC variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001394063.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 1 | 3 | |||
| missense | 11 | 2 | 1 | 14 | ||
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 16 | 2 | 2 | 20 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001380992.1 | 17 | MANE Select | |
| Ensembl | ENSP00000417122.2 | 17 | MANE Select | |
| RefSeq | NP_001338459.1 | 16 | Standard | |
| RefSeq | NP_001338460.1 | 11 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| zgc:162324 | Danio rerio | Structure: otolith Quality: morphology abnormal |
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000295966
- Coding exons
- 12
- Length
- 332719
- Individuals with no LoFs
- 125705
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 43
- Defined
- 125748
- p
- 0.000171
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.363 | 292 | 310 | 0.942 | 0.0000161 | 3704 |
| Missense (PolyPhen) | 95 | 91.316 | 1.0403 | 1121 | ||
| Synonymous | 0.118 | 113 | 115 | 0.986 | 0.00000626 | 1049 |
| Loss of Function | 1.90 | 21 | 32.7 | 0.642 | 0.00000186 | 354 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00019 | 0.00019 | rare |
| South Asian | 0.00038 | 0.00036 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
Intolerance Scores
- LoFtool
- 0.908
- RVIS EVS
- 0.49
- RVIS percentile EVS
- 79.55
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |